Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Narumi Numata"'
Autor:
Yohei Seki, Yasuo Yoshihara, Kiyoko Nojima, Haruka Momose, Shuetsu Fukushi, Saya Moriyama, Ayumi Wagatsuma, Narumi Numata, Kyohei Sasaki, Tomoyo Kuzuoka, Yoshiyuki Yato, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki, Takuo Mizukami, Isao Hamaguchi
SUMMARYBackgroundThe Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Japan in November 2021. This variant contains up to 36 mutations in the spike protein, the target of neutralizing antibodies, and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf7faa914b7c594808b9fc3ecdc1e1aa
https://doi.org/10.1101/2022.01.20.22269587
https://doi.org/10.1101/2022.01.20.22269587
Autor:
Yohei Seki, Yasuo Yoshihara, Kiyoko Nojima, Haruka Momose, Shuetsu Fukushi, Saya Moriyama, Ayumi Wagatsuma, Narumi Numata, Kyohei Sasaki, Tomoyo Kuzuoka, Yoshiyuki Yato, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki, Takuo Mizukami, Isao Hamaguchi
Publikováno v:
Med (New York, N.Y.). 3(6)
The Omicron variant of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was identified in Japan in November 2021. This variant contains up to 36 mutations in the spike protein, the target of neutralizing antibodies, and can escape vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598a4e5c20c94966c94a4403f45deee6
https://pubmed.ncbi.nlm.nih.gov/35815933
https://pubmed.ncbi.nlm.nih.gov/35815933
